Kathleen Glick

Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia

R. Gelber, S. Sallan, L. Silverman, 2000, Cancer.

Gemtuzumab Ozogamicin (GO) In Children With De Novo Acute Myeloid Leukemia (AML) Improves Event-Free Survival (EFS) By Reducing Relapse Risk – Results From The Randomized Phase III Children’s Oncology Group (COG) Trial, AAML0531

S. Raimondi, S. Meshinchi, T. Alonzo, 2013 .

Remission Rates In Childhood Acute Myeloid Leukemia (AML) Utilizing a Dose-Intensive Induction Regimen with or without Gemtuzumab Ozogamicin (GO): Initial Results From the Children's Oncology Group Phase III Trial, AAML0531

S. Raimondi, S. Meshinchi, T. Alonzo, 2010 .

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.

S. Raimondi, S. Meshinchi, T. Alonzo, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abnormalities Of 12p Are Associated With High-Risk Acute Myeloid Leukemia: A Children’s Oncology Group Report

S. Raimondi, S. Meshinchi, T. Alonzo, 2013 .

COG AAML03P1: Efficacy and Safety in a Pilot Study of Intensive Chemotherapy Including Gemtuzumab in Children Newly Diagnosed with Acute Myeloid Leukemia (AML)

S. Raimondi, R. Arceci, S. Meshinchi, 2008 .

High Mortality In Extreme Hyperleukocytosis In Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

S. Raimondi, S. Meshinchi, T. Alonzo, 2010 .

Multidimensional Flow Cytometry Significantly Improves Upon the Morphologic Assessment of Post-Induction Marrow Remission Status – Comparison of Morphology and Multidimensional Flow Cytometry; A Report From the Children's Oncology Group AML Protocol AAML0531

S. Raimondi, S. Meshinchi, T. Alonzo, 2011 .

Severe Toxicities During Pediatric Acute Myeloid Leukemia Chemotherapy: A Report From the Children's Oncology Group.

S. Raimondi, S. Meshinchi, T. Alonzo, 2010 .